The human body can excrete drugs and other exogenous molecules by converting them into polar, water-soluble compounds by a reaction similar to the autoxidation described in Section 11.6. Why are the following drug candidate molecules susceptible to oxidation by this pathway?

Oxidation reactions involve the loss of electrons or an increase in oxidation state by a molecule. In organic chemistry, this often includes the addition of oxygen or the removal of hydrogen. These reactions are crucial for the metabolism of drugs, as they can convert lipophilic compounds into more polar, hydrophilic forms that are easier for the body to excrete.

Polar compounds have a significant difference in electronegativity between atoms, leading to partial positive and negative charges, while nonpolar compounds do not have such charge separation. The human body tends to excrete polar compounds more efficiently because they are soluble in water, allowing for easier elimination through urine. Understanding the polarity of drug candidates helps predict their metabolic pathways.

Phase I metabolism refers to the initial chemical modifications made to drugs and other xenobiotics, primarily through oxidation, reduction, or hydrolysis. This process often introduces or exposes functional groups, making the compounds more polar and preparing them for further modification in Phase II metabolism, where conjugation occurs. Recognizing the role of Phase I reactions is essential for understanding how drugs are processed in the body.